Results 111 to 120 of about 23,156 (149)
Some of the next articles are maybe not open access.
Annals of Internal Medicine, 1986
Excerpt To the editor: Although the exact pathogenetic mechanism of hypercalcemia in sarcoidosis remains unknown, several studies (1-3) have suggested that the basic disturbance is an increase in c...
Noppen, Marc +3 more
openaire +3 more sources
Excerpt To the editor: Although the exact pathogenetic mechanism of hypercalcemia in sarcoidosis remains unknown, several studies (1-3) have suggested that the basic disturbance is an increase in c...
Noppen, Marc +3 more
openaire +3 more sources
Therapeutische Umschau, 2000
Eine Hyperkalzämie kann sich entwickeln, wenn von den Stellgliedern der Calciumhomöostase eines oder mehrere in ihrer Funktion gestört werden. Hyperkalzämische Erkrankungen können die Nebenschilddrüsen betreffen, sowie die von ihnen abhängigen Endorgane Nieren, Darm, Knochen.
openaire +3 more sources
Eine Hyperkalzämie kann sich entwickeln, wenn von den Stellgliedern der Calciumhomöostase eines oder mehrere in ihrer Funktion gestört werden. Hyperkalzämische Erkrankungen können die Nebenschilddrüsen betreffen, sowie die von ihnen abhängigen Endorgane Nieren, Darm, Knochen.
openaire +3 more sources
Annual Review of Medicine, 1987
Malignancy-associated hypercalcemia is a common and important clinical problem. Two major pathogenic mechanisms appear to be operative in this disorder: local osteolytic hypercalcemia and humoral hypercalcemia of malignancy. The clinical and biochemical features that distinguish these two processes are reviewed.
Karl L. Insogna, A E Broadus
openaire +3 more sources
Malignancy-associated hypercalcemia is a common and important clinical problem. Two major pathogenic mechanisms appear to be operative in this disorder: local osteolytic hypercalcemia and humoral hypercalcemia of malignancy. The clinical and biochemical features that distinguish these two processes are reviewed.
Karl L. Insogna, A E Broadus
openaire +3 more sources
Seminars in Oncology Nursing, 1999
To provide a review of hypercalcemia of malignancy, including the incidence, pathophysiology, signs and symptoms, treatment, and nursing interventions.Research studies, review articles, proceedings from nursing conferences, and book chapters.Hypercalcemia of malignancy is difficult to diagnose because the signs and symptoms are similar to those ...
openaire +2 more sources
To provide a review of hypercalcemia of malignancy, including the incidence, pathophysiology, signs and symptoms, treatment, and nursing interventions.Research studies, review articles, proceedings from nursing conferences, and book chapters.Hypercalcemia of malignancy is difficult to diagnose because the signs and symptoms are similar to those ...
openaire +2 more sources
Postgraduate Medicine, 1979
Hypercalcemia calls first for supportive measures, eg, adequate hydration, movement or mobilization of the patient to the greatest amount tolerated, and reevaluation of drugs being taken. When immediate lowering of the serum calcium level is not clinically mandatory, oral administration of furosemide, corticosteroid, or phosphorus should be considered.
Charles R. Kleeman +2 more
openaire +3 more sources
Hypercalcemia calls first for supportive measures, eg, adequate hydration, movement or mobilization of the patient to the greatest amount tolerated, and reevaluation of drugs being taken. When immediate lowering of the serum calcium level is not clinically mandatory, oral administration of furosemide, corticosteroid, or phosphorus should be considered.
Charles R. Kleeman +2 more
openaire +3 more sources
Pathophysiology of Hypercalcemia
Endocrinology and Metabolism Clinics of North America, 2021Extracellular calcium is normally tightly regulated by parathyroid hormone (PTH), 1,25-dihydroxyvitamin D, as well as by calcium ion (Ca++) itself. Dysregulated PTH production leading to hypercalcemia occurs most commonly in sporadic primary hyperparathryoidism (PHPT) but may also result from select genetic mutations in familial disorders.
openaire +2 more sources
The Journal of Steroid Biochemistry and Molecular Biology, 1992
Hypercalcemia may occur as a complication of haematological malignancies, in association with solid tumors with bone metastases, and with solid tumors in the absence of bone metastases. The latter syndrome, known as the humoral hypercalcemia of malignancy (HHM) shares many features with primary hyperparathyroidism. A parathyroid hormone-related protein
T.J. Martin, V. Grill
openaire +3 more sources
Hypercalcemia may occur as a complication of haematological malignancies, in association with solid tumors with bone metastases, and with solid tumors in the absence of bone metastases. The latter syndrome, known as the humoral hypercalcemia of malignancy (HHM) shares many features with primary hyperparathyroidism. A parathyroid hormone-related protein
T.J. Martin, V. Grill
openaire +3 more sources
Endocrinology and Metabolism Clinics of North America, 2021
Hypercalcemia of malignancy (HCM) is considered an oncologic emergency associated with significant symptom burden and increased comorbid conditions and mortality. Underlying pathologic processes most often stimulate osteoclast-mediated bone resorption.
openaire +2 more sources
Hypercalcemia of malignancy (HCM) is considered an oncologic emergency associated with significant symptom burden and increased comorbid conditions and mortality. Underlying pathologic processes most often stimulate osteoclast-mediated bone resorption.
openaire +2 more sources
Endocrinology and Metabolism Clinics of North America, 2021
Marcocci C., Cetani F.
openaire +3 more sources
Marcocci C., Cetani F.
openaire +3 more sources
Hypercalcemia and Hypertension
Annals of Internal Medicine, 1966Excerpt Hypertension as a sign of hypercalcemia has received little emphasis in the literature. Many current textbooks of medicine and endocrinology fail to mention the association while stressing ...
Robert H. Moser +2 more
openaire +3 more sources